Paracervical Versus Intracervical Lidocaine
1 other identifier
interventional
89
1 country
1
Brief Summary
The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize that intracervical block would produce lower pain scores than paracervical block at the time of cervical dilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2007
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 31, 2008
CompletedFirst Posted
Study publicly available on registry
January 5, 2009
CompletedResults Posted
Study results publicly available
August 13, 2019
CompletedAugust 13, 2019
July 1, 2019
2 months
December 31, 2008
June 4, 2019
July 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)
VAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain
at completion of procedure
Secondary Outcomes (1)
Gestational Age at Time of Procedure
At the time of the procedure
Study Arms (2)
1
ACTIVE COMPARATOR2
EXPERIMENTALInterventions
The paracervical block was administered using 20 ml of buffered lidocaine and a 5/8 inch, 25-gauge needle. A small amount was injected at the tenaculum site, and the remainder equally distributed around the cervicovaginal junction at 3, 5, 7, and 9 o'clock. The depth was standardized at 5/8 inch by inserting the needle to the hub.
The intracervical block was administered using 20 ml of buffered lidocaine and a 1-1/2 inch, 20 gauge needle in order to overcome the increased resistance to injection caused by the cervical stroma. A small amount was injected at the tenaculum site, and the remainder into the cervical stroma at 12, 3, 6, and 9 o'clock, at a depth of 1-1/2 inch by inserting the needle to the hub.
The buffered lidocaine preparation for both block techniques consisted of 50 mL of 1% lidocaine, 5 units of vasopressin, and 5 mL 8% sodium bicarbonate.
Eligibility Criteria
You may qualify if:
- Women presenting for elective first trimester abortion
You may not qualify if:
- Gestation over 12 weeks by ultrasound
- Weight less than 98 pounds
- Known allergy to lidocaine
- Known nonviable pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Planned Parenthood
San Diego, California, 92101, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jessica M. Kingston, MD
- Organization
- UC San Diego Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 31, 2008
First Posted
January 5, 2009
Study Start
December 1, 2007
Primary Completion
February 1, 2008
Study Completion
February 1, 2008
Last Updated
August 13, 2019
Results First Posted
August 13, 2019
Record last verified: 2019-07